Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

Clinical and Experimental Allergy

Volumn 31, Issue 9, 2001, Pages 1392-1397

  Pajno, G B ^a   Barberio, G ^a   De Luca, F R ^b   Morabito, L ^b   Parmiani, S ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Asthma; Children; House dust mite; New sensitizations; Rhinitis; Specific immunotherapy

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT;

AGE DISTRIBUTION; ARTICLE; ASTHMA; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT SENSITIZATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; GENDER; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; RHINITIS; TREATMENT OUTCOME; URTICARIA;

AIR POLLUTION, INDOOR; ANIMALS; ASTHMA; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; DUST; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION; MALE; MITES; POLLEN; RHINITIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; URBAN HEALTH;

EID: 0034847103     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01161.x     Document Type: Article

References (28)

1. WHO Position Paper. Allergen immunotherapy. Therapeutic vaccines for allergic diseases
2. Allergen immunotherapy for asthma
3. The appropriate use of skin testing and allergen immunotherapy in young children
4. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children
5. The benefit of specific allergy treatment
6. Immunotherapy as preventive treatment
7. Capacity of specific immunotherapy in prevention of allergic asthma in children: The Preventive Allergy Treatment Study (PAT)
8. Allergen standardization and skin tests
9. Pollen-related allergy in the European Mediterranean area
10. Sensitization to mite allergens is a risk factor for early and late onset of asthma and for persistence of asthmatic signs in children
11. Natural course of asthma and allergy in childhood
12. The natural history of IgE sensitization and atopic disease in early childhood
13. Indoor allergens and asthma: Report of the third international workshop
14. The combined influence of immunotherapy and mite allergen reduction on bronchial hyperresponsiveness in mite-sensitive asthmatic children
15. Effect of specific immunotherapy with house dust mite extract on the bronchial responsiveness of pediatric patients
16. Modification of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) or grass pollen
17. Specific immunotherapy prevents the onset of new sensitizations in monosensitized children
18. Immunologic changes associated with allergen immunotherapy
19. Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes
20. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing m-RNA for interferon-gamma
21. Bee venom immunotherapy results in a decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures
22. Allergen Immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals
23. Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells
24. Grass pollen immunotherapy, efficacy and safety during a 4-year follow-up study
25. The atopic diseases
26. Immunotherapy in children with allergic asthma, effect on bronchial hyperreactivity and pharmacotherapy